수의 감염증 진단 시장 규모, 점유율, 성장 분석 : 감염증 유형별, 기술별, 동물 유형별, 최종사용자별, 지역별 - 업계 예측(2026-2033년)

Veterinary Infectious Disease Diagnostics Market size was valued at USD 2.18 Billion in 2024 and is poised to grow from USD 2.38 Billion in 2025 to USD 4.73 Billion by 2033, growing at a CAGR of 9% during the forecast period (2026-2033).

The veterinary infectious disease diagnostics market is essential for the timely and effective diagnosis of animal diseases, enhancing prevention, control, and treatment measures that lead to better health outcomes. The increasing prevalence of infectious diseases, driven by factors such as globalization and changing husbandry practices, heightens the demand for reliable diagnostic solutions. However, challenges such as high costs, lack of skilled professionals, and inadequate infrastructure in certain regions can hinder market access and implementation. Despite these obstacles, opportunities abound through technological advancements, including rapid and point-of-care tests. Additionally, the rising awareness of zoonotic diseases and the One Health approach underline the importance of interconnected health systems, promoting growth in the veterinary infectious disease diagnostics sector for improved animal and public health globally.

Top-down and bottom-up approaches were used to estimate and validate the size of the Veterinary Infectious Disease Diagnostics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Veterinary Infectious Disease Diagnostics Market Segments Analysis

Global Veterinary Infectious Disease Diagnostics Market is segmented by Infection Type, Technology, Animal Type, End User and region. Based on Infection Type, the market is segmented into Bacterial Infections, Viral Infections, Parasitic Infections and Other Infections. Based on Technology, the market is segmented into Immunodiagnostics, Other immunodiagnostic technologies, Molecular Diagnostics, Other molecular diagnostic tests and Other Veterinary Diagnostic Technologies. Based on Animal Type, the market is segmented into Companion Animals, Other companion animals and Food Producing Animals. Based on End User, the market is segmented into Reference Laboratories, Veterinary Laboratories and Clinics, Point of Care / In House Testing and Research Institutes and Universities. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Veterinary Infectious Disease Diagnostics Market

The rising consciousness regarding animal health and welfare is a crucial factor propelling the veterinary infectious disease diagnostics market. As pet owners and livestock producers become more informed, they are actively pursuing advanced diagnostic tools and services to facilitate the early detection and efficient management of infectious diseases. This heightened awareness underscores the importance of monitoring animal health, especially in light of recent global health events that have emphasized the necessity for strong diagnostic capabilities to identify and address potential zoonotic diseases. Consequently, this increasing demand for reliable diagnostics continues to shape the market landscape significantly.

Restraints in the Veterinary Infectious Disease Diagnostics Market

A notable challenge facing the veterinary infectious disease diagnostics market is the high expense linked to advanced diagnostic technologies and services. The investment required for implementing state-of-the-art diagnostic tools and equipment can be prohibitive, particularly for smaller veterinary practices or clinics in under-resourced areas. This financial barrier may restrict the availability and use of these sophisticated diagnostic methods, ultimately impeding overall market expansion. As a result, the cost factor plays a crucial role in limiting the ability of veterinary professionals to adopt innovative solutions that could enhance the diagnosis and treatment of infectious diseases in animals.

Market Trends of the Veterinary Infectious Disease Diagnostics Market

The Veterinary Infectious Disease Diagnostics market is witnessing a significant trend towards the adoption of point-of-care testing (POCT), reflecting a shift towards real-time, rapid diagnostic capabilities in veterinary settings. These portable and user-friendly POCT devices empower veterinarians to conduct on-site tests, leading to immediate decision-making and improved patient outcomes. This trend not only streamlines the diagnostic process but also enhances the efficiency of veterinary care by reducing reliance on centralized laboratory facilities. Consequently, the market is evolving to prioritize innovative solutions that facilitate timely interventions in infectious disease management for animals, underscoring a growing demand for accessible diagnostic technology.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Veterinary Infectious Disease Diagnostics Market Size by Infection Type & CAGR (2026-2033)

• Market Overview
• Bacterial Infections
• Viral Infections
• Parasitic Infections
• Other Infections

Global Veterinary Infectious Disease Diagnostics Market Size by Technology & CAGR (2026-2033)

• Market Overview
• Immunodiagnostics
  • Lateral flow assays
  • ELISA tests
• Other immunodiagnostic technologies
• Molecular Diagnostics
  • Polymerase chain reaction (PCR) tests
  • Microarrays
• Other molecular diagnostic tests
• Other Veterinary Diagnostic Technologies

Global Veterinary Infectious Disease Diagnostics Market Size by Animal Type & CAGR (2026-2033)

• Market Overview
• Companion Animals
  • Dogs
  • Cats
  • Horses
• Other companion animals
• Food Producing Animals
  • Cattle
  • Swine
  • Poultry
  • Other food-producing animals

Global Veterinary Infectious Disease Diagnostics Market Size by End User & CAGR (2026-2033)

• Market Overview
• Reference Laboratories
• Veterinary Laboratories and Clinics
• Point of Care / In House Testing
• Research Institutes and Universities

Global Veterinary Infectious Disease Diagnostics Market Size & CAGR (2026-2033)

• North America (Infection Type, Technology, Animal Type, End User)
  • US
  • Canada
• Europe (Infection Type, Technology, Animal Type, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Infection Type, Technology, Animal Type, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Infection Type, Technology, Animal Type, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Infection Type, Technology, Animal Type, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• IDEXX Laboratories, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zoetis, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Virbac (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• bioMerieux SA (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Heska Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NEOGEN Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QIAGEN N.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Randox Laboratories Ltd. (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agrolabo S.pA. (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bionote, Inc. (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biogal Galed Labs (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioChek (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biopanda Reagents (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• URIT Medical Electric Co. Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MEGACOR Diagnostik GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fassisi GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Alvedia (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SKYER, Inc. (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations